Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Garcia-Foncillas

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|December 1, 1995
16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphomaJ E Romaguera, J Garcia-Foncillas, F Cabanillas
Oncology|February 5, 2010
MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancerV Boni, E Bandres, R Zarate, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2011
RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLCA Vilmar, J Garcia-Foncillas, M Huarriz, et al.
Psychology, Health & Medicine|June 26, 2015
Suicide ideation among oncologic patients in a Spanish wardD Diaz-Frutos, E Baca-Garcia, I Mahillo-Fernandez, et al.
American Journal of Clinical Oncology|August 1, 1993
Phase II evaluation of doxorubicin, ifosfamide, and dacarbazine plus amphotericin B in the treatment of metastatic soft tissue sarcomas. A pilot studyR González-Manzano, J M Vieitez, E Tangco, et al.
The Pharmacogenomics Journal|June 30, 2010
Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecanV Boni, R Zarate, J C Villa, et al.
British Journal of Cancer|October 14, 2010
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patientsA Abajo, J Rodriguez, N Bitarte, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2011
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapyJ Rodriguez, V Boni, A Hernández, et al.
British Journal of Cancer|June 16, 2012
Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patientsA Abajo, V Boni, I Lopez, et al.
The New England Journal of Medicine|November 9, 2000
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agentsM Esteller, J Garcia-Foncillas, E Andion, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|December 1, 1995
16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphomaJ E Romaguera, J Garcia-Foncillas, F Cabanillas
Oncology|February 5, 2010
MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancerV Boni, E Bandres, R Zarate, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2011
RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLCA Vilmar, J Garcia-Foncillas, M Huarriz, et al.
Psychology, Health & Medicine|June 26, 2015
Suicide ideation among oncologic patients in a Spanish wardD Diaz-Frutos, E Baca-Garcia, I Mahillo-Fernandez, et al.
American Journal of Clinical Oncology|August 1, 1993
Phase II evaluation of doxorubicin, ifosfamide, and dacarbazine plus amphotericin B in the treatment of metastatic soft tissue sarcomas. A pilot studyR González-Manzano, J M Vieitez, E Tangco, et al.
The Pharmacogenomics Journal|June 30, 2010
Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecanV Boni, R Zarate, J C Villa, et al.
British Journal of Cancer|October 14, 2010
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patientsA Abajo, J Rodriguez, N Bitarte, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2011
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapyJ Rodriguez, V Boni, A Hernández, et al.
British Journal of Cancer|June 16, 2012
Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patientsA Abajo, V Boni, I Lopez, et al.
The New England Journal of Medicine|November 9, 2000
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agentsM Esteller, J Garcia-Foncillas, E Andion, et al.
Pageof 2